United States Antihemophilic Factor Market Report 2018

March 2018 | 106 pages | ID: U459BD2BB56EN
QYResearch

Abstracts

In this report, the United States Antihemophilic Factor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antihemophilic Factor in these regions, from 2013 to 2025 (forecast).

United States Antihemophilic Factor market competition by top manufacturers/players, with Antihemophilic Factor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Shire (Baxter)
• Bayer
• CSL
• Pfizer
• Grifols
• Biogen
• Octapharma
• NovoNordisk
• Greencross
• Kedrion
• BPL
• Hualan Bio
• RAAS

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Recombinant Factor VIII
• Plasma-derived Factor VIII

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antihemophilic Factor Market Report 2018

1 ANTIHEMOPHILIC FACTOR OVERVIEW

1.1 Product Overview and Scope of Antihemophilic Factor
1.2 Classification of Antihemophilic Factor by Product Category
  1.2.1 United States Antihemophilic Factor Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Antihemophilic Factor Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Recombinant Factor VIII
  1.2.4 Plasma-derived Factor VIII
1.3 United States Antihemophilic Factor Market by Application/End Users
  1.3.1 United States Antihemophilic Factor Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 United States Antihemophilic Factor Market by Region
  1.4.1 United States Antihemophilic Factor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.3 Southwest Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.5 New England Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.6 The South Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.7 The Midwest Antihemophilic Factor Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Antihemophilic Factor (2013-2025)
  1.5.1 United States Antihemophilic Factor Sales and Growth Rate (2013-2025)
  1.5.2 United States Antihemophilic Factor Revenue and Growth Rate (2013-2025)

2 UNITED STATES ANTIHEMOPHILIC FACTOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antihemophilic Factor Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Antihemophilic Factor Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Antihemophilic Factor Average Price by Players/Suppliers (2013-2018)
2.4 United States Antihemophilic Factor Market Competitive Situation and Trends
  2.4.1 United States Antihemophilic Factor Market Concentration Rate
  2.4.2 United States Antihemophilic Factor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antihemophilic Factor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIHEMOPHILIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Antihemophilic Factor Sales and Market Share by Region (2013-2018)
3.2 United States Antihemophilic Factor Revenue and Market Share by Region (2013-2018)
3.3 United States Antihemophilic Factor Price by Region (2013-2018)

4 UNITED STATES ANTIHEMOPHILIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Antihemophilic Factor Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Antihemophilic Factor Revenue and Market Share by Type (2013-2018)
4.3 United States Antihemophilic Factor Price by Type (2013-2018)
4.4 United States Antihemophilic Factor Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ANTIHEMOPHILIC FACTOR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Antihemophilic Factor Sales and Market Share by Application (2013-2018)
5.2 United States Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIHEMOPHILIC FACTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antihemophilic Factor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Antihemophilic Factor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.2 Antihemophilic Factor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Antihemophilic Factor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Grifols
  6.5.2 Antihemophilic Factor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Grifols Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Biogen
  6.6.2 Antihemophilic Factor Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biogen Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Octapharma
  6.7.2 Antihemophilic Factor Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Octapharma Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 NovoNordisk
  6.8.2 Antihemophilic Factor Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 NovoNordisk Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Greencross
  6.9.2 Antihemophilic Factor Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Greencross Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Kedrion
  6.10.2 Antihemophilic Factor Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Kedrion Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 BPL
6.12 Hualan Bio
6.13 RAAS

7 ANTIHEMOPHILIC FACTOR MANUFACTURING COST ANALYSIS

7.1 Antihemophilic Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antihemophilic Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antihemophilic Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antihemophilic Factor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIHEMOPHILIC FACTOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Antihemophilic Factor Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Antihemophilic Factor Sales Volume Forecast by Type (2018-2025)
11.3 United States Antihemophilic Factor Sales Volume Forecast by Application (2018-2025)
11.4 United States Antihemophilic Factor Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antihemophilic Factor
Figure United States Antihemophilic Factor Market Size (K Units) by Type (2013-2025)
Figure United States Antihemophilic Factor Sales Volume Market Share by Type (Product Category) in 2017
Figure Recombinant Factor VIII Product Picture
Figure Plasma-derived Factor VIII Product Picture
Figure United States Antihemophilic Factor Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Antihemophilic Factor by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States Antihemophilic Factor Market Size (Million USD) by Region (2013-2025)
Figure The West Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2025)
Figure United States Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Antihemophilic Factor Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Antihemophilic Factor Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Antihemophilic Factor Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Antihemophilic Factor Sales Share by Players/Suppliers
Figure 2017 United States Antihemophilic Factor Sales Share by Players/Suppliers
Figure United States Antihemophilic Factor Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Antihemophilic Factor Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Antihemophilic Factor Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Antihemophilic Factor Revenue Share by Players/Suppliers
Figure 2017 United States Antihemophilic Factor Revenue Share by Players/Suppliers
Table United States Market Antihemophilic Factor Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Antihemophilic Factor Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Antihemophilic Factor Market Share of Top 3 Players/Suppliers
Figure United States Antihemophilic Factor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antihemophilic Factor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antihemophilic Factor Product Category
Table United States Antihemophilic Factor Sales (K Units) by Region (2013-2018)
Table United States Antihemophilic Factor Sales Share by Region (2013-2018)
Figure United States Antihemophilic Factor Sales Share by Region (2013-2018)
Figure United States Antihemophilic Factor Sales Market Share by Region in 2017
Table United States Antihemophilic Factor Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Antihemophilic Factor Revenue Share by Region (2013-2018)
Figure United States Antihemophilic Factor Revenue Market Share by Region (2013-2018)
Figure United States Antihemophilic Factor Revenue Market Share by Region in 2017
Table United States Antihemophilic Factor Price (USD/Unit) by Region (2013-2018)
Table United States Antihemophilic Factor Sales (K Units) by Type (2013-2018)
Table United States Antihemophilic Factor Sales Share by Type (2013-2018)
Figure United States Antihemophilic Factor Sales Share by Type (2013-2018)
Figure United States Antihemophilic Factor Sales Market Share by Type in 2017
Table United States Antihemophilic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Antihemophilic Factor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antihemophilic Factor by Type (2013-2018)
Figure Revenue Market Share of Antihemophilic Factor by Type in 2017
Table United States Antihemophilic Factor Price (USD/Unit) by Types (2013-2018)
Figure United States Antihemophilic Factor Sales Growth Rate by Type (2013-2018)
Table United States Antihemophilic Factor Sales (K Units) by Application (2013-2018)
Table United States Antihemophilic Factor Sales Market Share by Application (2013-2018)
Figure United States Antihemophilic Factor Sales Market Share by Application (2013-2018)
Figure United States Antihemophilic Factor Sales Market Share by Application in 2017
Table United States Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
Figure United States Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
Table Shire (Baxter) Basic Information List
Table Shire (Baxter) Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Shire (Baxter) Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Shire (Baxter) Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Bayer Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Bayer Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure CSL Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure CSL Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Pfizer Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Pfizer Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Grifols Basic Information List
Table Grifols Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Grifols Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Grifols Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Biogen Basic Information List
Table Biogen Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Biogen Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Biogen Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Octapharma Basic Information List
Table Octapharma Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Octapharma Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Octapharma Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table NovoNordisk Basic Information List
Table NovoNordisk Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NovoNordisk Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure NovoNordisk Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure NovoNordisk Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Greencross Basic Information List
Table Greencross Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Greencross Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Greencross Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Greencross Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Kedrion Basic Information List
Table Kedrion Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Kedrion Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Kedrion Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table BPL Basic Information List
Table Hualan Bio Basic Information List
Table RAAS Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihemophilic Factor
Figure Manufacturing Process Analysis of Antihemophilic Factor
Figure Antihemophilic Factor Industrial Chain Analysis
Table Raw Materials Sources of Antihemophilic Factor Major Players/Suppliers in 2017
Table Major Buyers of Antihemophilic Factor
Table Distributors/Traders List
Figure United States Antihemophilic Factor Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Antihemophilic Factor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Antihemophilic Factor Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Antihemophilic Factor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Antihemophilic Factor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Antihemophilic Factor Sales Volume (K Units) Forecast by Type in 2025
Table United States Antihemophilic Factor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Antihemophilic Factor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Antihemophilic Factor Sales Volume (K Units) Forecast by Application in 2025
Table United States Antihemophilic Factor Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Antihemophilic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Antihemophilic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Antihemophilic Factor Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources